ESC 365 - Impact of levosimendan in the renal function of heart failure patients: data from a 10-year cohort

HFA Premium Access

Impact of levosimendan in the renal function of heart failure patients: data from a 10-year cohort

Session: Poster Session 1 - Acute Heart Failure– Treatment

Topic: Pharmacotherapy

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Congress Session

12 more presentations in this session

Effect of serelaxin on worsening heart failure when added to standard therapy in European patients with acute heart failure: Results from the RELAX-AHF-EU study

Targeted interventions reducing late maternal death due to heart failure

Speaker: Doctor F. Azibani (Cape Town, ZA)

Association between high-dose spironolactone and decongestion in patients with acute heart failure

Speaker: Doctor C. Kapelios (London, GB)

Time to Furosemide Treatment and Outcomes in patients admitted for Acute Heart Failure

Speaker: Doctor D. Roque (Amadora, PT)

Use of levosimendan in the real world over the last 10 years - what to expect?

Access the full session

Poster Session 1 - Acute Heart Failure– Treatment

Speakers: Doctor F. Azibani, Doctor C. Kapelios, Doctor D. Roque

About the event

Heart Failure 2018 & World Congress on Acute Heart Failure

26 May - 29 May 2018

Sessions Presentations

Congress

This platform is supported by